Defeating dengue starts at home, but will hinge on scientific research

There are many promising drugs and vaccines for dengue in the pipeline, and it is worth investing in clinical trials.

There are many promising drugs and vaccines for dengue in the pipeline, and it is worth investing in clinical trials. ST PHOTO: GIN TAY
New: Gift this subscriber-only story to your friends and family

Even as Singapore is a leader in the fight against dengue on both the public health policy and research fronts, those of us living here find ourselves continuously challenged by the seasonal cycles of dengue surges.

From a broader perspective, Singapore is truly an island within the flood of dengue that inundates South-east Asia. Many Asian countries get hit far harder than we do. Bangladesh comes to mind, having met the tragic milestone in early September of reporting its highest number of deaths in a year, with more than 800 casualties.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.